Martin Cannon
Affiliations: | University of Arkansas for Medical Sciences, United States |
Area:
Microbiology Biology, Immunology, OncologyGoogle:
"Martin Cannon"Children
Sign in to add trainee| Aaruni Khanolkar | grad student | 2000 | UAMS |
| Kristina Bondurant | grad student | 2004 | UAMS |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luo Y, Shreeder B, Jenkins JW, et al. (2023) Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade. Journal For Immunotherapy of Cancer. 11 |
| Zhang Y, Gabere M, Taylor MA, et al. (2022) Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy. Frontiers in Oncology. 12: 1042250 |
| Nagalo BM, Zhou Y, Loeuillard EJ, et al. (2022) Characterization of Morreton Virus (MORV) as a Novel Oncolytic Virotherapy Platform for Liver Cancers. Hepatology (Baltimore, Md.) |
| Block MS, Dietz AB, Gustafson MP, et al. (2020) Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients. Nature Communications. 11: 5173 |
| Jenkins SV, Robeson MS, Griffin RJ, et al. (2019) Gastrointestinal tract dysbiosis enhances distal tumor progression through suppression of leukocyte trafficking. Cancer Research |
| Conrad SJ, Nounamo B, Cannon M, et al. (2019) Abstract TMIM-077: MYXOMA VIRUS ENHANCES TREATMENT BENEFIT OF CHEMOTHERAPY AND DENDRITIC CELL IMMUNOTHERAPY IN OVARIAN CANCER PRECLINICAL MODEL Clinical Cancer Research. 25 |
| Ou Y, Cannon MJ, Nakagawa M. (2018) Regulatory T Cells in Gynecologic Cancer. Moj Immunology. 6: 34-42 |
| Nounamo B, Liem J, Cannon M, et al. (2017) Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model. Molecular Therapy Oncolytics. 6: 90-99 |
| Goyne HE, Stone PJ, Burnett AF, et al. (2014) Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenase. Journal of Immunotherapy (Hagerstown, Md. : 1997). 37: 163-9 |
| Goyne HE, Cannon MJ. (2013) Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer. Frontiers in Immunology. 4: 382 |